MODERNA (MRNA.OQ) Trading
Live Chart & Price Analysis
View the real-time MODERNA (MRNA.OQ) quote and decide if you want to go long or short. Find insights, analysis, the latest news and other information to help you with your trading.
$192.3
-5.35%58.67% buyers
Followers
1,228
Annual change
646.22%
Daily price range:
Low
184.8
High
196.58
Trade MRNA
CFD trading involves risk
MRNA live price
Live Chart
Past performance is not a reliable indicator of future results.
Should you buy or sell MODERNA right now?
Based on NAGA Sentiment¹, 58.67% are buying MODERNA and 41.33% are selling MODERNA right now. However, opening a long or short position now depends on your risk tolerance, investment horizon, and MODERNA market outlook.
Selling
41.33%
58.67%
Buying
MODERNA price analysis
The price of MODERNA today, as of September 30, 2026, was $192.3. That's up 2.50% from last session's MODERNA closing price. The MODERNA price is declining this week. Compared to last week, the rate of MODERNA is down -2.10%, and it's up 26.60% from one month ago.
The 52-week MODERNA price high is $208.60, while the 52-week MODERNA price low is $22.19.
Year to date, MODERNA price is up 575.40% from the beginning of the year and has had a return of 575.40% in the last 12 months.
Low$184.80
Day's Range
Low$22.19
52w Range+1.2%
1h
+2.5%
24h
-2.1%
7d
+22.0%
14d
+26.6%
30d
+575.4%
1y
MODERNA trading insights
The crowd feels NEGATIVE about MODERNA, with a HIGH volume of news backing the NEGATIVE sentiment score². At the start of today's MODERNA trading session, the sentiment signal³ is BEARISH, indicating whether the MODERNA price is more likely to increase or decrease today and in the following days.
The level of news⁴ backing the sentiment score is HIGH, indicating how confident the markets are to buy MODERNA right now. The LOW subjectivity⁵ indicates that the MODERNA price is UNDERVALUED.
Sentiment Signal
Bearish
Next update: Oct 1, 12:30
Sentiment Score
Negative
40 / 100
Subjectivity
Low Subjectivity
17 / 100
Confidence Index
High
Discover key MODERNA trends with NAGA Insights
What am I Missing?
Make informed decisions based on real-time data, expert analysis, and powerful research tools from TipRanks.
Access advanced MODERNA charting, technical analysis, and live market data from TradingView.
Get AI-powered MODERNA trade signals, in-depth market analysis, and technical strategy insights from Trading Central.
CFD trading involves risk
How to trade MODERNA with leverage?
Trade MODERNA if you want flexibility to speculate on its price movements in both directions. With CFDs, you can open a buy position (go long) if you think the MODERNA price will rise, or you can open a sell position (go short) if you believe the MODERNA price will fall.
You won’t need to commit to the full value of the position (see the required margin below), but bear in mind that leverage can increase both your profits and losses.
If you want to speculate on MODERNA price, search for MODERNA CFD. Then click on the "MODERNA" symbol to view the chart and other insights before placing your trade. Also, review "MODERNA" contract specification to be aware of all the MODERNA CFD trading conditions.
trading conditions:
Platform
MT5
Platform spreads
Live: 0.3365
Ticker#MRNA.OQ
Margin (%)*
Volume step
Lot value
Minimum trade size
Maximum trade size
Commission0.00%
Monthly price change (%)36.80%
Annual price change (%)646.22%
Digits
Tick value0.009
Trading Hours & FeesCFD trading involves risk
About MODERNA
MRNA
Moderna
CFD
-5.35%
$192.68
$192.3
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
MODERNA price forecast, news, and analysis
Discover the latest news that can influence MODERNA’s earnings sentiment and MODERNA forecast and price predictions.
Neutral
Invesco S&P 500 Equal Weight ETF (RSP) Adds Moderna and NVR on Sept. 29
01/10/2026/07:03
Neutral
If I Could Tell Every New Investor 1 Thing About Building Wealth in the Stock Market, It's This
01/10/2026/03:05
FAQs about MODERNA trading
The price of MODERNA today, as of September 30, 2026, was 192.3. That's up 2.50% from the previous session's MODERNA closing price.
IMPORTANT NOTICE: The content presented in the instrument page is only for informational, educational and support purposes. The material presented, including analyses, sentiment, consensus, prices, opinions or other content, is not an investment recommendation or information that recommends or suggests an investment strategy, nor is it included in the scope of investment advice. NAGA will not accept liability for any loss or damage, including but not limited to any loss of profits, that may arise directly or indirectly from the use of or reliance on the information contained in this page. NAGA is not responsible for the actions or omissions of the client, especially for the acquisition or disposal of financial instruments, made based on the information contained in this page. Past performance is not necessarily indicative of future results, and anyone acting on this information does so at their own risk. ¹ NAGA sentiment reflects the positions held by active NAGA users who currently maintain open trades in a specific instrument. This information is provided for indicative purposes only and should not be interpreted as investment advice or a recommendation to trade. ² ³ ⁴ ⁵ The sentiment dashboard is provided by Trading Central. Sentiment insights and market views are based on available data and do not guarantee future performance.
Need Help? Visit our Help Section
Download NAGA Trader
Download NAGA Trader
Click the QR code to enlarge
Copyright © 2026 – All rights reserved.
NAGA is a trademark of The NAGA Group AG, a German based FinTech company publicly listed on the Frankfurt Stock Exchange | WKN: A41YCM | ISIN: DE000A41YCM0.
The website is operated by JME Financial Services (Pty) Ltd an authorised Financial Services Provider, regulated by the Financial Sector Conduct Authority in South Africa under license no. 37166. JME Financial Services (Pty) Ltd is located at Suite 10, 21 Lighthouse Rd 201 Beacon Rock, Umhlanga Rocks, Kwa-Zulu Natal, 4320, South Africa.
JME Financial Services (Pty) Ltd acts as an intermediary between the investor and NAGA Capital Ltd, the counterparty to the contract for difference purchased by the Investor via Naga.com/za. NAGA Capital Ltd is authorised and regulated by the Financial Services Authority Seychelles (FSA) under licence No. SD026. NAGA Capital Ltd is the principal to the CFD purchased by investors on this website. Other group entities: NAGA Markets Europe LTD which is authorised and regulated by the Cyprus Securities and Exchange Commission (CySEC) under licence No. 204/13.
RISK WARNING: Derivatives are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how derivatives work and whether you can afford to take the high risk of losing your money. The value of financial products can increase as well as decrease over time, depending on the value of the underlying securities and market conditions. Illustrations, forecasts or hypothetical data are not guaranteed and are provided for illustrative purposes only. JME Financial Services (Pty) Ltd does not render advice in respect of the CFD’s offered on this website. Before making an investment decision, you should rely on your own assessment. The Company’s disclaimer, conflict of interest policy are available on legal documents section.